Residency Program
The Drug Information Group at the University of Illinois is an academic and consultative unit of the College of Pharmacy and provides clinical support to organizations in need. The goals of the Group are to provide evidence-based medical information, to enhance the skills of health care professionals through training sessions, and to serve as a resource for health care professionals involved in patient care.
The UIC PGY2 residency in drug information is a 12-month program designed to enhance clinical skills and to develop expertise in:
- efficient retrieval of drug information
- online database searching
- critical analysis of drug literature
- scientific writing
- statistical analysis
- didactic and experiential teaching
The resident will also gain experience in the operation and management of a drug information group as well as project management. Elective experiences are available in industry, patient safety, poison information, pharmacoeconomics, and research. A unique opportunity exists for the resident to participate in the development of monographs and prior authorization criteria for the Illinois Department of Healthcare and Family Services.
The resident will participate in the resident seminar series, resident report, journal club, and the UIC resident teaching certificate program. The resident will be required to initiate and conduct a drug information-related research project. Rotations may be individualized according to the goals and qualifications of the applicant.
The resident will have an academic appointment at the University of Illinois at Chicago College of Pharmacy and will engage in the co-precepting of students, and serve as a lecturer and recitation facilitator for the drug information and statistics course.
A Doctor of Pharmacy degree and completion of a pharmacy practice residency (PGY1) are required. The appointment will be for 12 months beginning July 2, 2012. A competitive salary and benefits package is offered.
For additional information or to apply, please contact:
Amy E. Lodolce, PharmD, BCPS
University of Illinois at Chicago
College of Pharmacy
833 South Wood Street, M/C 886
Chicago, Il 60612
Phone : (312) 355-4049
Fax (312) 996-0448
E-mail: aelo@uic.edu
PGY2 Drug Information Residency Links
- Application (due January 6, 2012)
- Letter of Recommendation Form
- ASHP PGY2 Drug Information Goals and Objectives
Faculty
Michael Gabay, PharmD, JD, BCPS
Amy Lodolce, PharmD, BCPS
Carissa E. Mancuso, PharmD
Mary Lynn Moody, BS Pharm
Rita Soni, PharmD, BCPS
Joan Stachnik, PharmD, BCPS
Maria Tanzi, PharmD
Courtney Krueger, PharmD, BCPS
Heather Ipema, PharmD
Recent Publications (2002 – present)
Schiff GD, Galanter WL, Duhig J, Lodolce AE, Koronkowski MJ, Lambert BL. Principles of conservative prescribing. Arch Intern Med. 2011; ahead of print June 13, 2011.
Ipema HJ, Lodolce AE, Mancuso CE . Survey of drug information activities of ASHP-accredited pharmacy practice residency programs. Am J Health Syst Pharm. 2011;68(13):1194-1195.
Burda AT, Ipema HJ, Wahl MS. Self-treatment of acetaminophen overdose with dietary-supplement acetylcysteine. Am J Health Syst Pharm. 2011;68(9):786-787.
Segreti J, Garcia-Houchins S, Gorski L, Moureau N, Shomo J, Zack J, Stachnik J, Tanzi M, Moody ML. Consensus conference on prevention of central line-associated bloodstreatm infections: 2009. J Infus Nurs. 2011;34(2):126-133.
Hong IS, Ipema HJ, Gabay MP, Lodolce AE. Medication repurposing: new uses for old drugs. J Pharm Technol. 2011;27(3):132-140.
Dandeles LM, Lodolce AE. Efficacy of agents to prevent and treat enteral feeding tube clogs. Ann Pharmacother. 2011;45(5):676-680.
Hong I, Stachnik J. Unlabeled uses of factor VIIa (recombinant) in pediatric patients. Am J Health Syst Pharm. 2010;67(22):1909-1919.
Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging (MRI). Hosp Pharm. 2010;45(10):771-778.
Posey LM, Tanzi MG. Diabetes care: model for the future of primary care. J Am Pharm Assoc (2003). 2010;50(5):623-626.
Mancuso CE, Gabay MP, Steinke LM, VanOsdol SJ. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1. Ann Pharmacother. 2010;44(7-8):1240-1249.
Ellinger LK, Ipema HJ, Stachnik JM. Efficacy of metformin and topiramate in prevention and treatment of antipsychotic-induced weight gain. Ann Pharmacother. 2010;44(4):668-679.
Ipema HJ, Jung MY, Lodolce AE Romiplostim management of immune thrombocytopenic purpura. Ann Pharmacother. 2009;43(5):914-919.
Sanborn M, Gabay M, Moody ML. The safety of intravenous drug delivery systems: update on current issues since the 1999 consensus development conference. Hosp Pharm. 2009;44(2):159-164.
Sanborn MD, Moody ML, Harder KA, Pepper GA, Scanlon M, Vaida AJ, et al. Second consensus development conference on the safety of intravenous drug delivery systems—2008. Am J Health Syst Pharm. 2009;66(2):185-192.
Tanzi, MG. ACC 57th Annual Scientific. Pharmacy Today (Washington D C). 2008;14(5):27-29.
Schoen, M, Tanzi, MG. Role of calcium channel blockers in treatment of hypertension. Pharmacy Today (Washington D C). 2008;14(4):50-61.
Lodolce AE. Labeling changes for ESAs: historical overview and current best practices. Pharmacy Net Guide. 2008;(6):6-10.
Leong H, Stachnik J, Bonk ME, Matuszweski KA. Unlabeled uses of intravenous immune globulin. Am J Health Syst Pharm. 2008;65(19):1815-1824.
Stachnik J. Pharmacotherapy of hemoptysis: a pharmacologist perspective. Multidisciplinary Respir Med. 2008;3(4):314-318.
Gabay M, von Martius K. Comparative evaluation of collapsible versus semi-rigid intravenous containers. Technol Health Care. 2008;16(6):429-435.
Berberet B, Burda A, Breier C, Lodolce AE. Discontinuation of 5% alcohol in 5% dextrose injection: implications for antidote stocking. Am J Health Syst Pharm. 2008;65(23):2200, 2300.
Stachnik JM, Nunn-Thompson C. Use of atypical antipsychotics in the treatment of autistic disorder. Ann Pharmacother. 2007;41(4):626-634.
Boullata JI, Mancuso CE. A "how-to" guide to prepare abstrcats and poster presentations. Nutr Clin Pract. 2007:22(6):641-646.
Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Bisphosphonate-induced osteonecrosis of the jaw. Ann Pharmacother. 2007;41(2):276-284.
Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy. 2006;26(9):1314-1319.
Gabay M . Absorbable hemostatic agents. Am J Health Syst Pharm. 2006;63(13):1244-1253.
Stachnik JM . Rituximab in the treatment of acquired hemophilia. Ann Pharmacother. 2006;40(6):1151-1157.
Stachnik J . Inhaled anesthetic agents. Am J Health Syst Pharm. 2006;63(7):623-634.
Berberet BR, Burda AM, Lodolce AE. Unavailability of 10% alcohol in 5% dextrose injection. Am J Health Syst Pharm. 2005;62(22):2344-2345.
Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of i.v. drug administration. Am J Health Syst Pharm. 2005;62(9):917-920.
Patka JH, Lodolce AE, Johnston AK. High- versus low-dose oxytocin for augmentation or induction of labor. Ann Pharmacother. 2005;39(1):95-101.
Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacother. 2004;24(9):1177-1185.
Mancuso CE, Paloucek FP. Understanding and preparing for pharmacy practice residency interviews. Am J Health Syst Pharm. 2004;61(16):1686-1689 .
Gabay MP, Costianis R. Restricted drug distribution programs. Am J Health Syst Pharm. 2003;60(15):1525-1530.
Vasquez EM, Tanzi M, Benedetti E, Pollak R. Medication noncompliance after kidney transplantation. Am J Health Syst Pharm. 2003;60(3):266-269.
Tanzi MG, Gabay MP. Association between honey consumption and infant botulism. Pharmacother. 2002;22(11):1479-1483.
Gabay MP, Jain R. Role of antibiotics for the prevention of cardiovascular disease. Ann Pharmacother. 2002;36(10):1629-1636.
Gabay MP . Galactogogues: medications that induce lactation. J Hum Lact. 2002;18(3):274-279.
Stachnik JM, Gabay MP. Continuous infusion of coagulation factor products. Ann Pharmacother. 2002;36(5):882-891.